fluoxetine has been researched along with 3-(3,5-dichlorophenyl)-1-methyl-2,5-pyrrolidinedione in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Graf-Boxhorn, S; Hermanns, T; Poeck, B; Strauss, R | 1 |
1 other study(ies) available for fluoxetine and 3-(3,5-dichlorophenyl)-1-methyl-2,5-pyrrolidinedione
| Article | Year |
|---|---|
Octopamine mediates sugar relief from a chronic-stress-induced depression-like state in Drosophila.
Topics: 5-Hydroxytryptophan; Animals; Depression; Depressive Disorder, Major; Dopaminergic Neurons; Drosophila; Fluoxetine; Humans; Mammals; Octopamine; Selective Serotonin Reuptake Inhibitors; Serotonin; Succinimides; Sucrose; Sugars | 2022 |